October 2006

Published monthly by: USIS
245 S. 84th St.
Lincoln, NE
68501-2089
Phone:
800-288-8504
Fax:
402-483-7949

Subscription rate:
Free to enrolled clients

Newsletter Contacts –
Lincoln, NE

Director of Operations:
Arlene Horky


Marketing Specialist:
Sarah Houk

Materials in this newsletter may not be reproduced without permission. We welcome your comments and suggestions.
The USIS mission is to support our clients with quality driver screening and substance abuse testing information, products and services. We strive for excellence as we fulfill our promises and raise the level of integrity in the workplace.

Reminder:


The end of CY 2006 is less than three months away. For those organizations regulated by the Department of Transportation (DOT), have you accomplished all of your supervisor and employee training?

If not, USIS can provide a solution with On-line DOT Supervisor Drug and Alcohol Training.

Fast: When and where you need it, DOT Supervisor Drug and Alcohol Training reaches one location or hundreds of locations.

Easy: Self-paced and user-friendly, DOT Supervisor Drug and Alcohol Training can train one supervisor or hundreds of supervisors.

Effective: DOT Supervisor Drug and Alcohol Training is tailored to each individual.

Inexpensive: On-line DOT Supervisor Drug and Alcohol Training saves your company time and money.

Visit our website at www.stsfirst.com/usisindex.asp to purchase online or call at 800-288-8504 ext. 3244.

Regulatory Updates:

From the U.S. DOT Office of Drug and Alcohol Policy and Compliance (ODAPC)

ODAPC recently published an updated list of Frequently Asked Questions (FAQs) that pertain to drug and alcohol testing programs regulated by the DOT under 49 CFR Part 40. The following four questions are frequently asked and are especially relevant:

Question:
Are employers and their service agents in the Department of Transportation (DOT) drug and alcohol testing program required to obtain employee written authorizations in order to disclose drug and alcohol testing information?

Read More

Did You Know?

Meth Labs

Instances of methamphetamine trafficking and abuse in the United States are on the increase. As a result, this drug is having a devastating impact on communities across the nation.

Clandestine production accounts for nearly all of the methamphetamine trafficked and abused in the United States. Domestic methamphetamine production, trafficking, and abuse are concentrated in the Western, Southwestern, and Midwestern United States. Methamphetamine is also increasingly available in portions of the South and Eastern United States, especially Georgia and Florida. Clandestine laboratories in California and Mexico are the primary sources of supply for methamphetamine available in the U.S.

Methamphetamine is clandestinely manufactured using the ephedrine or pseudoephedrine reduction method. In this process, over-the-counter cold and allergy tablets containing ephedrine or pseudoephedrine are placed in a solution of water, alcohol, or other solvent for several hours until the ephedrine or pseudoephedrine separates from the tablet. Then, using common household products and equipment and a recipe learned from friends or taken off the Internet, the ephedrine or pseudoephedrine is converted into high quality Methamphetamine in makeshift, illegal labs by untrained individuals.

Household products contain most of the necessary chemicals to complete the manufacturing process. Certain brands of drain cleaner, for instance, have a high concentration of sulfuric acid. When mixed with table or rock salt, hydrogen chloride gas is produced for use in the final stage of methamphetamine production. The hydrogen chloride gas procedure as well as other procedures are extremely dangerous and can cause death or serious injury not only to the individuals making the methamphetamine, but to others who may be living in an adjoining house or apartment. Additionally, the chemical vapors produced during cooking permeate the walls and carpets of houses and buildings, making them uninhabitable.

 

Published by USIS
Copyright © 2006 USIS. All rights reserved.

This mail was sent to you as a service of USIS. It was our understanding that you wish to receive this and future mailings. If you do not wish to receive any email communication from USIS, please click unsubscribe here.